| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Laboratorio di Farmacologia e Tossicologia Ambientali, Istituto di Ricerche Farmacologiche "Mario Negri," 20157 Milan, Italy [M. B., C. M., A. G., R. B., M. M., R. F., L. A.], and Dipartamente di Scienze Chimiche, Università di Camerino, 62032 Camerino (MC), Italy [P. G.]
A sensitive, specific, and rapid method for quantitating the minor adduct O6-butylguanine (O6BuG) in hydrolyzed DNA has been developed by combining immunoaffinity chromatography and high resolution gas chromatography-negative ion chemical ionization-mass spectrometry.
Polyclonal antibodies raised against O6BuG were coupled to CNBr-activated Sepharose 4B and used for sample clean-up and extraction of the specific O6-alkylguanine. After addition of O6BuG and its deuterium labeled analogue (O6BuG-D7), used as internal standard, hydrolyzed DNA was applied on the immunoaffinity column and washed with water, and the immunoadsorbed butylated guanines were eluted with acetone/water cetome/water (95/5) before gas chromatographic derivatization. O6BuG and O6BuG-D7 were analyzed and quantitated by high resolution gas chromatography-negative ion chemical ionization-mass spectrometry as their pentafluorobenzyl-trimethylsilyl derivatives. Immunoaffinity column capacity and O6BuG recovery from this column were 1.53 nmol O6BuG/column and 62 ± 5%, respectively.
The method was applied to evaluate O6BuG levels in DNA butylated in vitro with 10 mM N-nitroso-Nr-butylurea or isolated from rats given an i.p. dose of 185 mg/kg N-nitroso-N-butylurea or N-nitrosodibutylamine. In the first case the level of modifications present in calf thymus DNA was 104 µmol O6BuG/mol guanine, and in the second case O6BuG in liver DNA was about 6 times higher after N-nitroso-N-butylurea (2.11 µmol O6BuG/mol guanine) than after N-nitrosodibutylamine (0.34 µmol O6BuG/mol guanine) treatment.
These results indicate that O6BuG formed in vivo can be isolated and quantitated by this method, which may also be useful for studying DNA damage and repair mechanisms.
1 This work was supported by the Italian National Research Council, Special Project "Oncology," Contract 88.01115.44, and by NATO Grant 0675/88.
2 To whom requests for reprints should be addressed, at Istituto di Richerche Farmacologiche "Mario Negri," Via Eritrea 62, 20157 Milan, Italy.
Received 3/12/90. Accepted 7/30/90.
This article has been cited by other articles:
![]() |
D. S. Hage Affinity Chromatography: A Review of Clinical Applications Clin. Chem., May 1, 1999; 45(5): 593 - 615. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |